DE102006022908A1 - Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten - Google Patents

Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten Download PDF

Info

Publication number
DE102006022908A1
DE102006022908A1 DE102006022908A DE102006022908A DE102006022908A1 DE 102006022908 A1 DE102006022908 A1 DE 102006022908A1 DE 102006022908 A DE102006022908 A DE 102006022908A DE 102006022908 A DE102006022908 A DE 102006022908A DE 102006022908 A1 DE102006022908 A1 DE 102006022908A1
Authority
DE
Germany
Prior art keywords
group
use according
protozoan
alkyl
substituted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE102006022908A
Other languages
German (de)
English (en)
Inventor
Wolfgang Dr. Bohne
Uwe Prof. Dr. Groß
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEORG-AUGUST-UNIVERSITAET GOETTINGEN STIFTUNG , DE
Original Assignee
Georg August Universitaet Goettingen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Georg August Universitaet Goettingen filed Critical Georg August Universitaet Goettingen
Priority to DE102006022908A priority Critical patent/DE102006022908A1/de
Priority to PCT/DE2007/000879 priority patent/WO2007131488A2/fr
Publication of DE102006022908A1 publication Critical patent/DE102006022908A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE102006022908A 2006-05-15 2006-05-15 Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten Withdrawn DE102006022908A1 (de)

Priority Applications (2)

Application Number Priority Date Filing Date Title
DE102006022908A DE102006022908A1 (de) 2006-05-15 2006-05-15 Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten
PCT/DE2007/000879 WO2007131488A2 (fr) 2006-05-15 2007-05-15 Utilisation de dérivés de quinolone comme agents antiprotozoaires et dans des associations médicamenteuses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006022908A DE102006022908A1 (de) 2006-05-15 2006-05-15 Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten

Publications (1)

Publication Number Publication Date
DE102006022908A1 true DE102006022908A1 (de) 2007-11-22

Family

ID=38607850

Family Applications (1)

Application Number Title Priority Date Filing Date
DE102006022908A Withdrawn DE102006022908A1 (de) 2006-05-15 2006-05-15 Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten

Country Status (2)

Country Link
DE (1) DE102006022908A1 (fr)
WO (1) WO2007131488A2 (fr)

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Journal of Medicinal Chemistry 17(2), 255-256 (1974) *

Also Published As

Publication number Publication date
WO2007131488A3 (fr) 2008-01-31
WO2007131488A2 (fr) 2007-11-22

Similar Documents

Publication Publication Date Title
DE69023748T2 (de) Verwendung von Stickstoff enthaltenden Makrozyklen zur Behandlung retroviraler Infektionen.
DE3636123C2 (fr)
AU2014228324B2 (en) Pharmaceutical composition of S-ketamine hydrochloride
JP2017081930A (ja) ラキニモドおよび酢酸グラチラマーを組み合わせた多発性硬化症の治療
DE68906345T2 (de) Antimalariazusammenstellungen, gebrauchmachend von Quinidin, Artemisinin und ihren Derivaten.
DE3786893T2 (de) Piperidinderivat zur Schmerzbehandlung.
KR20080009088A (ko) 말라리아를 치료하기 위한 페로퀸과 아르테미시닌 유도체의복합 제제
DE69400631T2 (de) Verwendung von rifamycinderivaten zur herstellung eines arzneimittels zur behandlung der toxoplasmose
DE68921413T2 (de) Verbindungen und Zusammensetzungen zur Anwendung bei Methoden zur Behandlung und Prophylaxe von Pneumocystis Carinii Pneumonia und anderen Krankheiten.
DE68903092T2 (de) Laktamimide in der behandlung arzneiresistenter protozoeninjektionen.
DE69006707T2 (de) Verwendung von Fluorochinolon-Derivaten zur Behandlung der Pneumocystis carinii Pneumonie.
EP0290959A2 (fr) Mélange de médicaments pour la prophylaxie et thérapie de la malaria
JPWO2016171282A1 (ja) 近視予防剤及び近視進行抑制剤
EP0214101A2 (fr) Utilisation des fer(III) chelateurs du type desferrioxamine-B et desferriferrithiocine pour le traitement du paludisme
DE19858253A1 (de) Verwendung von Inhibitoren des KQt1-Kanals zur Herstellung eines Medikaments zur Behandlung von Krankheiten, die durch Helminthen und Ektoparasiten hervorgerufen werden
DE69936186T2 (de) Dihydroartemisinin-Formulierung zur Behandlung von verschiedenen Typen von Malaria
DE69926794T2 (de) Ponazuril zur behandlung von durch coccidia neurologischen und "abortigenic" verursachten erkrankungen
EP0214933A2 (fr) Préparations à base de mélanges pour le traitement de la malaria
DE2820991C2 (fr)
US10179115B2 (en) Methods for treating malaria using potassium channel inhibitors
DE60032777T2 (de) Zusammensetzung zur behandlung von virusinfektionen, die einen calcium-kanal-blocker und ein chinolin enthält
DE102006022908A1 (de) Verwendung von Chinolonderivaten als antiprotozoäre Mittel und in Kombinationspräparaten
US11491162B2 (en) Combination of quinoline-4-carboxamides and benzonaphthyridine derivatives as antimalarial drug combination
JP2001507672A (ja) Ｃｉｓ―縮合シクロペンテノ―１，２，４―トリオキサン誘導体を含有する抗マラリア組成物
EP1638577B1 (fr) Preparation pharmaceutique destinee au traitement de maladies tropicales parasitaires contenant diminazene diaceturate

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8127 New person/name/address of the applicant

Owner name: GEORG-AUGUST-UNIVERSITAET GOETTINGEN STIFTUNG , DE

R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20111201